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Abstract
Background: Genetic studies of human lung function and Chronic Obstructive Pulmonary Disease have identified a
highly significant and reproducible signal on 4q24. It remains unclear which of the two candidate genes within this
locus may regulate lung function: GSTCD, a gene with unknown function, and/or INTS12, a member of the Integrator
Complex which is currently thought to mediate 3’end processing of small nuclear RNAs.
Results: We found that, in lung tissue, 4q24 polymorphisms associated with lung function correlate with INTS12 but
not neighbouring GSTCD expression. In contrast to the previous reports in other species, we only observed a minor
alteration of snRNA processing following INTS12 depletion. RNAseq analysis of knockdown cells instead revealed
dysregulation of a core subset of genes relevant to airway biology and a robust downregulation of protein synthesis
pathways. Consistent with this, protein translation was decreased in INTS12 knockdown cells. In addition, ChIPseq
experiments demonstrated INTS12 binding throughout the genome, which was enriched in transcriptionally active
regions. Finally, we defined the INTS12 regulome which includes genes belonging to the protein synthesis pathways.
Conclusion: INTS12 has functions beyond the canonical snRNA processing. We show that it regulates translation by
regulating the expression of genes belonging to protein synthesis pathways. This study provides a detailed analysis of
INTS12 activities on a genome-wide scale and contributes to the biology behind the genetic association for lung
function at 4q24.
Keywords: Integrator Complex, INTS12, snRNA processing, Protein synthesis, Regulation of gene expression,
Pathway dysregulation, Histone modification, Accessible chromatin, Transcription
Background
According to the World Health Organization, respira-
tory diseases such as Chronic Obstructive Pulmonary
Disease (COPD) are one of the leading causes of popula-
tion morbidity and mortality [1]. COPD is characterized
by irreversible airway obstruction, and one or both of
emphysema and chronic bronchitis. Clinically, COPD is
defined by lung function parameters, the forced vital
capacity and the forced expiratory volume in the first
second [2]. Since the beginning of genome-wide
association studies (GWAS), efforts were undertaken to
further our understanding of the pathobiology of this
disease. Several studies have identified highly significant
associations between single nucleotide polymorphisms
(SNPs) on chromosome 4q24 and lung function as well
as risk of COPD [3–6]. However, the mechanistic basis
of this signal has not been elucidated. To understand the
functional basis for this region, we have previously used
expression quantitative trait locus (eQTL) analyses in
multiple non-lung tissues and found the strongest evi-
dence supported the hypothesis that the variable expres-
sion of Integrator Complex subunit 12 gene (INTS12)
underlies this association [7].
INTS12 protein is a member of Integrator Complex
(INTScom) currently believed to be composed of
approximately 14 subunits [8]. This complex was shown
to stably accompany the C-terminal tail of RNA poly-
merase II (POLII) and at a molecular level has been
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implicated in small nuclear RNA (snRNA) biogenesis
[9–12] dynein recruitment to the nuclear envelope at
the mitotic onset [13] and with POLII pause and release
[14]. At the physiological level, targeted knockdown and
mutagenesis experiments demonstrated INTScom to be
necessary for mouse adipogenesis [15], zebrafish haemo-
poiesis [16] as well as human primary ciliogenesis [17].
The relative contributions of individual subunits in the
above processes vary.
Direct insights into the function of INTS12 come from
Drosophila where it is necessary for the spliceosome’s
snRNA processing and this function is considered to be
canonical [10–12]. Drosophila’s INTS12 was also impli-
cated in the activation of a key heat shock response gene
HSP70Aa [14]. In HeLa cells, INTS12 was specifically
shown to be required for the maintenance of perinuclear
dynein [13] and formation of primary cilia [17].
Although ciliogenesis is a dynein-dependent event [18, 19]
it is thought that INTS12 is regulating these two processes
separately from each other via the snRNA processing
pathway [17]. INTS12 is also likely to play important roles
in embryonic development. This has been supported by
studies which showed that homozygous INTS12 knockout
in M. musculus results in pre-weaning lethality [7]. The
lethal effect of INTS12 knockout most probably occurs in
utero as breeding heterozygous models only yields wild-
type homozygotes or mutant heterozygotes but never
produces homozygous litters with no functional copy of
the gene (data not shown). In Drosophila, the evolutionary
conserved INTS12’s plant homeodomain (PHD) is
dispensable for the canonical snRNA processing [12]
suggesting the probable existence of other functions for
this protein. Thus although numerous INTS12 dependent
cellular functions have been reported, no studies have
addressed by which molecular mechanisms these func-
tions are implemented.
Here we investigate the regulatory properties of
INTS12 in primary human bronchial epithelial cells
(HBECs) to help understand the biological mechanism
behind the association signal for lung function at 4q24
locus. As no genome-wide molecular assessment of
INTS12 perturbation has been performed to date, we
use a hypothesis-free approach [20] by combining gene
knockdown with RNA sequencing in order to generate
new functional hypotheses. We bioinformatically show
that INTS12 has homology to epigenetic regulators of
gene expression. As this molecule was shown to interact
with genomic DNA in flies [14], we performed chromatin
immunoprecipitation followed by sequencing (ChIPseq)
and combined it with RNAseq data. Our data show that
INTS12 acts as a regulator of pathways fundamental for
protein synthesis, including the tRNA synthetases, PERK
and unfolded protein response pathways. We provide in-
sights into the characteristics of INTS12 binding as well
as its relationship to transcription and propose a model
for INTScom activity that may explain the plethora of
phenotypes observed upon depletion of various members
of the complex. Finally, we suggest that variation in
INTS12 expression conferred by specific eQTL alleles,
dictates the levels of protein synthesis and thus may in
part be contributing to the genetic association for lung
function.
Results
Lung function SNPs are eQTLs for INTS12 expression in
the lung tissue
The association signal for lung function within 4q24
contains a peak situated over two oppositely transcribed
genes in close proximity to each other, the Glutathione
S-transferase, C-terminal Domain Containing (GSTCD)
and INTS12. Based on eQTL analyses in non-lung tis-
sues, it has been suggested that INTS12 is a more likely
contributor to the pulmonary function than GSTCD
(Obeidat et al. 2013). To confirm this observation, we
have taken advantage of a RNAseq-based human lung
eQTL dataset from the Genotype-Tissue Expression pro-
ject [21]. There were 248 SNPs at or near 4q24 that were
significant cis-eQTLs for INTS12 expression (n = 278,
false discovery rate (FDR) < 0.05). Among these, 30 SNPs
showed significant association for lung function in the
SpiroMeta consortium study [3]. In contrast, none of
these variants showed significant association with
GSTCD expression (Table 1). This finding indicates that
within 4q24 it is the altered expression of INTS12, and
not GSTCD, that is influencing lung function.
Human INTS12 knockdown has modest effects on snRNA
processing in HBECs
Given previous observations in Drosophila implying a
role for INTS12 in processing of U1, U2, U4 and U5
snRNAs [10–12], we first set out to determine if these
observations translate to a human model. Because
INTS12 expression is higher in the human bronchial epi-
thelium than other airway structural cells [7] we concen-
trated our studies on primary HBECs grown to passage
three. Quantitative PCR (qPCR) assays measuring mis-
processed U1, U2, U4 and U5 snRNAs were developed.
We then validated transfection conditions and demon-
strated knockdown, both at the mRNA (Fig. 1a) and
protein levels (Fig. 1b, Additional file 1: Figure S1), with
two different Dicer substrate siRNAs (D-siRNAs) [22]
targeting INTS12.
Transfection of primary cultures of HBECs with
D-siRNAs A and C produced 91 ± 2% and 82 ± 3%
knockdown of INTS12, respectively (Fig. 1c). In contrast
to findings in Drosophila, no significant effects on U1 pro-
cessing were seen. A role for INTS12 on U2 processing
was found, with fold increases in U2 immature product by
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2.58 ± 0.58 and by 2.64 ± 0.59 for D-siRNAs A and C re-
spectively (P < 0.05; Fig. 1c). However, in keeping with the
lack of impact on U1 processing, we found no significant
effects of INTS12 knockdown on processing of U4 and
U5 snRNAs. These data suggest that whilst INTS12 may
play a role in U2 processing, it does not significantly affect
processing of U1, U4, and U5 snRNAs in HBECs. Due to
ubiquitous expression of snRNA genes [9–11], we cannot
exclude the possibility that effects on other snRNA species
were not observed due to the requirement for a more ro-
bust INTS12 protein knockdown than was achieved.
However, a survey of published studies that investigated
the importance of INTS12, indicates a potentially weaker
role for this molecule in delivering snRNA processing
relative to other INTScom members (Additional file 2:
Table S6).
Sequence analysis of open reading frames (ORF) from
66 metazoan species revealed high levels of INTS12 con-
servation, particularly its PHD (Fig. 2a). The observed
effects on snRNA processing together with the detected
conservation prompted us to hypothesize the existence
of additional functions for INTS12. Moreover, the
evolutionary constrained PHD finger is dispensable for
snRNA processing in Drosophila [12]. In order to gain
insight into the potential INTS12 functions, a search of
similar human proteins was performed using the
BLASTP algorithm [23] (Fig. 2b). INTS12’s PHD ap-
peared to be homologous to a large family of fingers
whose functions lie in the control of chromatin and nu-
cleosomes [24] where they act as epigenetic regulators of
gene expression (Additional file 2: Table S1 and S2).
Therefore, we next aimed to study the genome-wide
regulatory properties of INTS12 by using a combination
of gene knockdown with transcriptome profiling and
patterns of binding to the genomic DNA.
Differential transcriptome analysis reveals regulation of a
core regulome subset of relevance to airway biology
In order to identify a core subset of genes that are sig-
nificantly regulated by INTS12 we compared the acute
versus longer term transcriptomic responses due to de-
pletion. RNAseq profiling was performed 48 h and 120 h
Table 1 INTS12 cis-eQTLs at 4q24 locus
SNP Position FEV1 P-value INTS12 eQTL FDR INTS12 effect size GSTCD eQTL FDR GSTCD effect size
rs11732650 106973680 6.83E-09 0.000397993 −0.53 1 0
rs11722225 106985879 7.08E-09 0.000397993 −0.53 1 0
rs11726124 106985945 6.63E-09 0.000397993 −0.53 1 0
rs11728716 106975445 8.44E-09 0.000397993 −0.53 1 0
rs17036090 106813023 3.84E-08 0.000397993 −0.51 1 0.01
rs11735851 106916703 1.90E-09 0.000397993 −0.51 1 0.02
rs17036225 106929541 3.33E-09 0.000397993 −0.51 1 0.02
rs11736859 106928234 2.86E-09 0.000397993 −0.51 1 0.02
rs11727745 106935976 5.47E-09 0.000397993 −0.51 1 0.02
rs10516528 106959042 6.27E-09 0.000397993 −0.51 1 0.02
rs17036139 106852106 1.25E-09 0.000397993 −0.51 1 0.02
rs11727189 106838589 3.38E-09 0.000397993 −0.51 1 0.02
rs11731417 106965461 5.96E-09 0.000397993 −0.53 1 0
rs11733287 106924788 2.32E-09 0.000397993 −0.53 1 0
rs11728044 106824235 1.95E-09 0.000397993 −0.51 1 0.02
rs11733225 106924812 2.34E-09 0.000397993 −0.51 1 0.02
rs10516525 106887474 1.44E-09 0.000397993 −0.51 1 0.02
rs11724839 106857705 1.79E-09 0.000397993 −0.51 1 0.02
rs10516526 106908353 6.67E-10 0.000397993 −0.51 1 0.02
rs17036142 106854185 1.11E-09 0.000397993 −0.51 1 0.02
rs12374256 106836810 1.88E-09 0.000658031 −0.52 1 0.03
rs11097901 106949382 6.32E-09 0.000953622 −0.47 1 0.02
Genome-wide significant SNPs for lung function parameter forced expiratory volume in the first second (FEV1) also correlate with INTS12 expression in the human
lung (FDR < 0.001). This observation is not true for the expression of neighbouring GSTCD, supporting the hypothesis that altered expression of INTS12 is driving
the association signal for lung function. Effect size is defined as the slope of linear regression line relative to reference allele normalized as an expression of 1. The
eQTL data was obtained from Genotype-Tissue Expression project, while per SNPs lung function significance values in linkage disequilibrium with INTS12 (r2 > 0.8)
are from Repapi et al. study (Repapi et al. 2010)[3]
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after RNA interference (RNAi). After 48 h the levels of
knockdown were 74 ± 1% and 78 ± 2%, whilst after
120 h, 89 ± 1% and 80 ± 2% for D-siRNAs A and C re-
spectively (FDR < 0.05). After accounting for off-target
and transfection effects there were 67 and 1939 differen-
tially expressed genes by INTS12 knockdown at 48 h
and 120 h time points respectively (FDR < 0.05; Fig. 3a
and b). Thus, sustained knockdown resulted in a differ-
ential expression of ~30 times more genes than what
was observed in acute response to knockdown (Fig. 3c).
For those genes showing altered levels at both time
points, called core regulome subset, the magnitude of
A
B
C
Fig. 1 Optimizing INTS12 knockdown and elucidating its effect on snRNA processing in HBECs. a Optimizing anti-INTS12 D-siRNA transfections.
INTS12 mRNA expression in HBECs transfected with three distinct D-siRNAs at 10nM (left) and with the indicated concentrations of D-siRNA A and
C (right). D-siRNAs A and C at a concentration of 1nM were chosen for subsequent experiments. Statistical tests were performed comparing to
scrambled D-siRNA control: *P< 0.05, **P< 0.01, ***P< 0.001. Individual ΔΔCt gene expressions are GAPDH normalized and relative to the mean of
scrambled D-siRNA condition. b Representative images of INTS12 protein expression in anti-INTS12 D-siRNA transfected HBECs by immunofluorescence.
c INTS12 mRNA expression in HBECs transfected with D-siRNA A and C (left) and corresponding fold changes in misprocessed snRNAs (right). Statistical
tests were performed comparing to scrambled D-siRNA control: *P < 0.05, ****P < 0.0001. Individual ΔΔCt gene expressions are GAPDH normalized and
relative to the mean of scrambled D-siRNA condition
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change was greater at 120 h post initiation of RNAi
(Fig. 3d) for all except one (Fig. 3e). Crucially the direc-
tion of differential expression for this set of genes is the
same in the independent D-siRNAs treatments and at
both time points (Fig. 3e, Table 2).
Genes showing altered expression include a number of
genes known to play important roles in lung disease
such as α1-antitrypsin (SERPINA1) [25], transforming
growth factor β 1 (TGFβI) [26], interleukin 1 receptor 1
(IL1R1) [27] and IL6, IL8, IL1B, IL1A [28–31]. We have
calculated the P-value of observing such an association
of “lung biology genes” with the list of core regulome as-
suming the null hypothesis of their independence given
the background of protein coding genes. Surprisingly in
the light of global effects of INTS12 depletion (Fig. 3b),
this analysis allowed us to reject the null hypothesis in
favour of the alternative (P < 0.0001). IL6 had the great-
est reduction in expression. The gene with the greatest
fold induction was Leptin (LEP) which was shown to be
upregulated and secreted from HBECs infected with
respiratory syncytial virus [32] (Table 2). Interestingly,
several polymorphisms in linkage with LEP are associ-
ated with lung function [33]. LEP blood concentration
was also shown to negatively correlate with lung func-
tion [34]. Crucially, we have biologically validated LEP
upregulation in an additional donor HBECs depleted of
INTS12 (Additional file 1: Figure S2). These findings
suggest that altered expression of INTS12 in population
A
B
Fig. 2 Sequence analysis of INTS12’s PHD and its sequence similarity to epigenetic regulators of gene expression. a Quantitative assessment of
INTS12 conservation using a repertoire of 66 metazoan open reading frames. The ratio of non-synonymous changes to synonymous changes
(dN/dS) is shown throughout the protein. dN/dS approaching zero indicate strong and significant conservation (n = 66 species): red colour P < 0.1, blue
colour P > 0.1. P-value represents the probability of observed dN/dS ratio given the null the hypothesis of neutral evolution. b Full length INTS12
protein sequence (NP_001135943.1) BLASTP against a database of Homo sapiens protein sequences shows the sequence similarity to be exclusively
within the PHD. PHD appears as a putative zinc and histone H3 binding site
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studies may at least in part contribute to lung biology
as well as, more broadly, potentially towards other
phenotypes.
In relation to the above findings it is of interest
whether INTS12 can work independently from the rest
of the INTScom complex or if it mediates tissue-specific
functions via this complex. To begin to address this
question we have performed a correlation analysis of
known INTScom members using our entire 48 h and
120 h expression RNA-seq datasets. It appeared that
average Pearson’s correlation coefficients are −0.13 and
0.22 at 48 h and 120 h respectively for INTS12 mRNA
expression in relation to the other INTS proteins
(Additional file 1: Figure S12). Therefore, in HBECs,
A
D E
B C
Fig. 3 Differential transcriptome analysis reveals regulation of a core subset of genes relevant to airway biology. Statistical tests were performed
comparing to scrambled D-siRNA control: all significantly deregulated genes had FDR < 0.05. a Venn diagrams of significantly deregulated genes
at 48 h in the indicated conditions. 46 reproducibly deregulated genes plus 21 out of 61 genes deregulated in all three comparisons but in
opposite direction in INTS12 knockdown conditions when compared to un-transfected vs. scrambled D-siRNA analysis were shortlisted from 48 h
dataset (total 67). b Venn diagrams of significantly deregulated genes at 120 h. 1660 reproducibly deregulated genes plus 279 out of 1333 genes
deregulated in all three comparisons but in opposite direction in INTS12 knockdown conditions when compared to un-transfected vs. scrambled
D-siRNA analysis were shortlisted from 120 h dataset (total 1939). c Comparison of 48 h and 120 h transcriptomic responses to INTS12 knockdown.
The two gene sets contain 39 common with overrepresentation of genes of relevance to airway biology. d Box plot of log2 fold changes in gene
expression observed in 48 h and 120 h transcriptomic responses to gene knockdown using D-siRNA A. Sustained depletion resulted in greater fold
changes of gene expression. e Log2 fold changes of 39 common genes significantly deregulated at 48 h and 120 h using D-siRNA A. Genes have
greater effect sizes in 120 h response for all except one
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Table 2 Deregulation of a core regulome genes due to INTS12 knockdown
48 h and 120 h
consensus genes
FOLD CHANGES
48 h 120 h
Scrambled vs D-siRNA A Scrambled vs D-siRNA C Scrambled vs D-siRNA A Scrambled vs D-siRNA C
LEP 4.51 16.62 29.16 23.41
AC005863.1 3.35 3.90 9.60 5.55
OLFML2A 1.71 2.55 8.02 2.71
SESN3 2.98 2.01 6.80 2.53
TNS1 2.66 4.73 6.43 6.12
NEK7 2.42 2.30 5.67 3.95
MAN1A1 1.82 2.03 5.26 2.67
MAF 2.81 4.89 4.56 5.47
BMF 3.81 3.48 4.49 4.49
SCPEP1 1.53 1.56 3.76 1.26
PBXIP1 1.88 2.14 3.49 2.32
CBX1 2.04 2.28 3.01 3.39
ENDOD1 1.80 1.82 2.99 3.04
SGK1 1.63 1.54 2.89 1.93
HSPB1 1.65 1.47 2.75 1.48
RNF152 1.55 1.84 2.55 1.97
SERPINA1 2.85 2.71 2.48 2.79
PGAM1 1.64 1.70 2.47 2.02
ASPH 1.59 1.66 2.44 2.37
MAMDC2 2.56 3.17 2.43 7.40
SHROOM2 1.66 1.95 2.42 1.80
EPHB2 1.55 2.12 2.20 2.63
ITGB6 1.84 2.47 2.19 4.01
IL1R1 2.16 2.02 2.16 1.66
TGFBI 1.99 2.75 2.00 5.83
SLITRK6 1.80 2.11 1.86 2.62
PNRC2 1.63 1.56 1.31 1.36
PHACTR3 0.43 0.53 0.43 0.52
IL8 0.45 0.49 0.42 0.18
CRCT1 0.34 0.54 0.39 0.58
CNOT6 0.59 0.64 0.39 0.56
LIF 0.43 0.41 0.38 0.35
KRT80 0.58 0.38 0.32 0.33
CXCL3 0.43 0.35 0.28 0.20
IL1B 0.52 0.38 0.17 0.33
CXCL5 0.54 0.47 0.17 0.34
IL1A 0.55 0.65 0.09 0.49
IL6 0.33 0.48 0.03 0.20
The table is showing the fold changes of consensus differentially expressed genes after 48 h and 120 h since the D-siRNA A and C transfections
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INTS12 seems to be expressed independently from the
rest of INTScom members and potentially operating
independently.
Differential pathway analysis identifies dysregulation of
protein synthesis and collagen formation pathways
following INTS12 knockdown
RNAseq transcriptomic profiling of cells depleted of
INTS12 for 120 hours was used to generate novel func-
tional hypotheses, because of improved silencing and
greater number of expression changes observed at this
time point (Fig. 3c). To identify pathways dysregulated
as a result of knockdown, Gene Set Enrichment Analysis
(GSEA) [35] was used leveraging 4722 curated gene sets
from the Molecular Signatures Database which included
1320 canonical pathway definitions [36–38]. To provide
internal replication and account for off-target effects
[39], we performed GSEA analyses separately following
treatment with either D-siRNA A or C, comparing
scrambled D-siRNA treated cells to INTS12 depleted
cells. Additionally, un-transfected cells were compared
with scrambled D-siRNA treated cells to account for
pathways that may be altered following treatment with
non-specific D-siRNA as artefacts of the experimental
exposure rather than being causally related to the gene
knockdown. Pathways reproducibly perturbed by both
D-siRNAs (FDR < 0.05) but not affected by scrambled
D-siRNA treatment were shortlisted and finally top dys-
regulated pathways were identified based on enrichment
score ordering.
Using this method three pathways were upregulated
and eight pathways were downregulated (Fig. 4a). Colla-
gen formation and extracellular matrix organization
pathways were the top two upregulated pathways (Fig. 4a,
Additional file 1: Figure S3, Figure S4, Figure S5). The
top two downregulated pathways were cytosolic tRNA
aminoacylation and PERK regulated gene expression
(Fig. 4b, Fig. 4c) which is a sub-pathway of the unfolded
protein response (Additional file 1: Figure S3, Figure S6,
Figure S7). We also observed significant downregulation of
other protein metabolism related pathways, including acti-
vation of genes by activating transcription factor 4 (ATF4)
and glycine, serine and threonine metabolism pathways
(Fig. 4a, Additional file 1: Figure S6, Figure S7). ATF4 ex-
pression was reduced by 70 ± 5% and 45 ± 2% in D-siRNA
A and C transfected cells when compared to scrambled D-
siRNA transfected cells respectively (FDR < 0.05) suggesting
an impact on integrated stress response [40]. Dysregulation
of these pathways was not observed when comparing un-
transfected cells to scrambled D-siRNA cells (Fig. 4c).
Overall, we observed greater number of dysregulated gene
sets meeting the statistical significance (Fig. 4a), larger
effect sizes (Additional file 1: Figure S3), higher number of
genes contributing to enrichment score (i.e. leading edge
group), greater enrichment scores (Fig. 4B, Additional
file 1: Figure S4, Figure S6) and lower variance of gene
expression (Fig. 4c, Additional file 1: Figure S5, Figure S7)
among the downregulated pathways. This suggests that
INTS12 knockdown predominantly results in gene and
pathway downregulation. Although these experiments
cannot specify whether mechanistically these effects are
directly or indirectly caused by INTS12, it is possible to
say that they were initiated by INTS12 knockdown and
thus may be causally attributed to the levels of this gene.
INTS12 is a regulator of protein synthesis and
proliferative capacity
In order to validate the RNAseq data, the expression of
methionyl-tRNA synthetase (MARS) and glycyl-tRNA
synthetase (GARS) genes from the tRNA synthetases
pathway and ATF4 and Asparagine Synthetase (ASNS)
genes from the PERK pathway were assessed by qPCR.
Analysis revealed the correlation of differences in gene
expression derived from RNAseq and qPCR estimates to
be 0.99 (Fig. 5a). The effect of knockdown on genes be-
longing to these top two downregulated pathways was
confirmed by independent experiments in cells from an
additional donor. Importantly INTS12 was suppressed
by 72 ± 4% and 86 ± 2% in the validation donor for
D-siRNA A and C respectively versus 93 ± 1% and 85 ± 2%
in the discovery donor for D-siRNA A and C respectively
which was mirrored by magnitude of changes observed
among the assayed target genes (Fig. 5b). These data fur-
ther support the regulatory effect of INTS12 upon protein
translation pathways.
Because of INTS12 knockdown induced downregulation
of several key pathways involved in protein metabolism
and translational control, the question was whether this
manipulation would affect cellular translation phenotype.
As predicted, INTS12 silencing repressed protein synthe-
sis by 23 ± 3% and 47 ± 3% in D-siRNA A and C respect-
ively (Fig. 5c). Since cell division requires doubling of
protein content prior to separation, we also conjectured
that INTS12 depletion would affect the cells’ capacity to
proliferate. Interestingly, counts revealed 25 ± 13% and 48
± 4% decrease of total cell numbers in D-siRNAs A and C
conditions respectively (Fig. 5d), mirroring the observed
reduction in protein synthesis. Thus the observed molecu-
lar signature impacted the relevant phenotypes, demon-
strating INTS12 as a regulator of genes forming part of
translational pathways.
Characterization of INTS12 binding sites and their
association with fixed elements
The observed regulation of protein synthesis genes could
be either indirect, e.g. through disruption of cell homeo-
stasis, or more direct, e.g. via control of gene transcrip-
tion or a post-transcriptional mechanism. It is not clear
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which of these scenarios is the case. Therefore, we aimed
to test the hypothesis that its binding might be enriched
for promoters of genes differentially expressed following
knockdown by performing ChIPseq [41] using two inde-
pendent donors’ HBECs and an antibody that we tested
to be specific for INTS12 (Additional file 1: Figure S1).
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of dot reflects the number of statistically significant differentially expressed gene. The location of dot reflects enrichment score in pathway
analysis. b Enrichment plots of cytosolic tRNA aminoacylation and PERK regulated gene expression pathways in D-siRNA A analysis. The FDR values
were 0.0004 and 0.002 while normalized enrichment scores were −2.05 and −1.95 for tRNA aminoacylation and PERK regulated gene expression
respectively. c Heatmaps of genes belonging to tRNA aminoacylation and PERK regulated gene expression pathways. Samples were clustered by
unsupervised hierarchical clustering and resulted in clustering of three biological replicate samples of each of the four conditions: un-transfected cells
(UT), cells transfected with scrambled D-siRNA negative control (NC), cells transfected with anti-INTS12 D-siRNA A (A) and cells transfected with
anti-INTS12 D-siRNA C (C). Green and red colours on the Z-scale indicate lower and higher expression respectively
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Fig. 5 Technical, biological and phenotypic validation of the INTS12 knockdown impact on the protein synthesis pathways. a Technical validation
of RNAseq findings by qPCR. Differences in gene expression derived from RNAseq strongly and significantly correlate with differences in gene
expression derived from qPCR. Validation assays were performed on the same samples that were used for RNAseq study. b Biological validation
of downregulation of genes belonging to cytosolic tRNA aminoacylation and PERK pathways in HBECs from the discovery donor (used in RNAseq) and
in an additional donor (validation donor). Statistical tests were performed comparing to scrambled D-siRNA control: *P < 0.05, **P < 0.01, ***P < 0.001,
****P < 0.0001. Individual ΔΔCt gene expressions are GAPDH normalized and relative to the mean of the scrambled D-siRNA condition. c Amino acid
incorporation measured by counts per methionine (CPM) in 120 h since the start of RNAi radiolabelling experiment. Statistical tests were performed
comparing to scrambled D-siRNA control: *P < 0.05, ***P < 0.001. Individual CPM values are normalized to the amount of total protein and are shown
as relative to the mean of the un-transfected condition. d HBEC counts at the beginning and at the end of 120 h INTS12 knockdown experiment.
Statistical tests were performed comparing to scrambled D-siRNA control: *P < 0.05, ***P < 0.001
Kheirallah et al. BMC Genomics  (2017) 18:248 Page 10 of 20
We also intended to investigate INTS12 interaction with
both fixed features [42] and cell-type-specific regulatory
elements of the human genome [43, 44]. Out of a total
of 37142070, 47776470 and 42932683 reads, 78.3%, 78.4
and 77.4% were uniquely mappable, while 81.9%, 83.0
and 93.0% were non-redundant in the first, second
donor and isotype control respectively.
We first tested inter-donor reproducibility of the
ChIPseq signal. Peak calling revealed that there were
70772 and 51377 binding sites in the first and second
donor respectively (FDR < 0.05). An inter-donor associ-
ation test of ChIPseq signal in active regions demon-
strated a significant correlation of 0.85 implying strong
biological reproducibility (Additional file 1: Figure S8).
In order to verify sequencing results, three positive sites
and one negative site were selected for further validation
by ChIP-PCR in each ChIP sample. The number of
binding events per thousand cells derived from ChIP-
PCR corresponded well with the observed ChIPseq sig-
nal validating our sequencing results (Additional file 1:
Figure S9).
The top three fixed genomic features associated with
INTS12 binding were intron, intergenic and promoter
(transcriptional start site (TSS) ± 3000 bp) regions. In
the first donor they occupied 37.2%, 30.5 and 16.8%,
while in the second donor they intersected with 34.9%,
23.7 and 21.4% of the total binding sites respectively
(Fig. 6a). We noted that 74.9 and 78.5% of all promoter
binding occurred proximally to TSS in the first and sec-
ond donor respectively. In agreement, a gene-centric
analysis over a meta-gene body (collection of hg19
RefSeq genes), revealed INTS12 binding to be in close
proximity to the TSS (Fig. 6b).
Next we performed a correlation analysis of INTS12
binding sites with the number of annotated genes and
with the nucleotide length of each chromosome. INTS12
binding in both donors correlated very well with the
number of genes (Fig. 6c). Correlations with chromo-
some length were notably weaker (Fig. 6c), indicating
that INTS12 is more likely to regulate gene expression
rather than being ‘merely distributed’ across the chro-
mosomes. Based on this analysis we conclude that
INTS12 binding sites along the genome are closely cor-
related with genes.
Since the canonical function of INTS12 is processing of
snRNAs [9] our initial prediction was that it would be pri-
marily enriched over the bodies of snRNA genes and less
so for other gene classes. However, our observation of the
widespread distribution of INTS12 binding (Additional
file 1: Figure S10) prompted us to test for binding enrich-
ment over the bodies of other gene classes. We tested pro-
tein coding, snRNA, small nucleolar RNA (snoRNA),
microRNA, and long intergenic RNA (lincRNA) genes,
and found that protein coding and snRNA genes show the
highest enrichment for INTS12 binding (Fig. 6d). For
protein-coding genes, peak binding is proximal to the TSS
while for snRNA genes the binding is enriched down-
stream of the transcriptional end site (TES). Of note, the
peak binding for lincRNA genes is near the TSS as for the
protein coding genes. The enrichment near TES for
snRNA genes is in agreement with INTS12 role as part of
snRNA processing machinery which occurs simultan-
eously to the nascent transcription of 3’box elements [9].
In summary, the observed different patterns of binding
over these protein coding and snRNA regions suggest dis-
tinct functional activities for INTS12 depending on the
class of the genes it binds to.
Association of INTS12 binding with specific regulatory
elements
We next examined the localisation of INTS12’s binding in
relation to specific regulatory elements identified in HBECs
[45]. Because bioinformatic searches indicated INTS12’s
PHD motif domain to be a candidate nucleosomal histone
3 tail binding protein, we tested the intersection of repre-
sentative INTS12 binding with reference localizations of
histone 3 lysine 4 trimethylation (H3K4me3), histone 3
lysine 36 trimethylation (H3K36me3), and histone 3 lysine
27 trimethylation (H3K27me3) modifications using per-
chromosome randomization test [46] (Fig. 7a, Additional
file 1: Figure S11). 58% of INTS12 binding co-localized
with H3K4me3 (Z-score = 348), 21% with H3K36me3
(Z-score = 13), and 4% with H3K27me3 (Z-score = −12).
Interestingly, 96% of INTS12 binding occurred in the
vicinity of HBECs’ DNaseI accessible chromatin signature
(Z-score = 223). INTS12 also overlapped with CTCF insu-
lator protein at 60% of its binding sites (Z-score = 264).
In addition to testing the relationship between cross-
binding of INTS12 and cell type variable mobile element
sites we also examined the overall correlation of their
respective ChIPseq signals on a genome-wide scale
(Fig. 7b). In agreement with our initial observations,
INTS12 signal most strongly correlated with accessible
chromatin (ρ = 0.83) followed by H3K4me3 (ρ = 0.74).
H3K36me3, CTCF and H3K27me3 had weaker correla-
tions of 0.61, 0.58, and 0.06 respectively. Since gene-
centric analysis revealed INTS12 binding to be enriched
near TSS we also examined the correlation of ChIPseq
signals at the promoters. In this analysis, the strongest
correlation was observed between INTS12 and H3K4me3
(ρ = 0.80) outweighing the correlation between INTS12
and DNaseI (ρ = 0.73). Correlations with H3K36me3,
CTCF and H3K27me3 were weak at the promoters being
0.3, 0.3, and −0.29 respectively.
Overall, based on these data, it is possible to say that
INTS12 binding closely associates with the canonical
marks of active transcription i.e. H3K4me3 and DNaseI.
On a genome-wide scale INTS12 appears to be closely
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associated with DNaseI signature, while at the promoter
regions INTS12 is more highly associated with
H3K4me3 modification. The identified binding sites are
likely to be biologically active as INTS12 peak regions
(±500 bp in both directions from the peak summit) show
stronger evolutionary conservation when compared with
proximal neighbouring regions (Fig. 7c). INTS12 regions
appeared more evolutionary conserved than CTCF sites,
and interestingly, CTCF binding locations are much more
narrowly conserved (±80 bp in both directions from the
peak summit) than what is observed for INTS12. These
representative observations from the first donor are
A
B
C D
Fig. 6 Summary of INTS12 binding to fixed features of the human genome. a Percentage of INTS12 binding sites falling on the fixed annotated
genomic features in the first (left) and second (right) donor. b Gene-centric analysis of INTS12 binding in the first donor across the gene bodies
of all the known human genes shows clear localization near the TSS. c Relationship of INTS12 binding to the gene number per each chromosome
and chromosome length. Analysis of binding versus number of genes revealed Pearson’s correlations of 0.93 and 0.95 in the first and second
donor respectively. Instead, correlations of binding sites and chromosome length are weaker being 0.73 and 0.63 for the first and second donor
respectively. d Comparison of INTS12 binding in the first donor across the bodies of protein coding, snRNA, snoRNA, lincRNA, and microRNA genes
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recapitulated in the second donor and therefore our study
provides supporting evidence of recruitment of INTS12
into transcriptionally active loci which may be modulated
via its binding to histone 3 and recognition of H3K4me3
modification.
Combination of ChIPseq and RNAseq reveals INTS12
regulome
To provide insights into the dynamics of INTS12 regula-
tion, we have overlaid ChIPseq and RNAseq datasets. As
INTS12 showed the highest enrichment with DNaseI
A
B
C
Fig. 7 Summary of INTS12 binding with HBEC epigenetic regulatory elements. a Percent of total INTS12 binding sites overlapping with HBEC-specific
regulatory elements. Data from the first donor is shown as a representative of the two donors tested. Colour indicates the Z-score of the distance
between the observed overlap and the mean of distribution of random overlap permutations. Negative Z-score implies that the observed overlap is
less than expected by chance. Higher Z-score implies larger distance to the mean of distribution in a randomization test. Within P < 0.05 the maximum
Z-score in random permutation walk is 8, 6, 4, 7 and 3 for H3K4me3, H3K36me3, H3K27me3, DNaseI, and CTCF respectively. The features most
prominently localizing with INTS12 are H3K4me3 (Z-score = 348) and DNaseI (Z-score = 223) both marking transcriptionally active regions as well as
CTCF (Z-score = 264). b Cross-correlations of INTS12 and HBEC specific regulatory elements ChIPseq signals on a genome-wide scale and in the
promoter regions (TSS ± 3000 bp). Numbers represent Pearson’s correlations between ChIPseq signals of respective reference datasets. c Evolutionary
conservation of INTS12 binding sites in vertebrates. The figure is showing the average phastcons score derived from multiple sequence alignment of
vertebrate genomes, across the binding sites of INTS12 (red) and CTCF protein (blue)
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and H3K4me3 sites, both marking active transcription
[47, 48], and poor correlation with H3K27me3, which
marks silenced loci [47], we examined whether these ob-
servations agree with gene expression in basal HBECs.
INTS12 had 8-fold higher enrichment of binding near
the TSS of expressed genes (defined as having greater
than zero fragments per kilobase per million reads
(FPKM) in at least one biological replicate). On the
other hand, INTS12 had only 1.2-fold enrichment of
binding over silenced genes (defined as having zero
FPKM in three biological replicates) (Fig. 8a). The mag-
nitude of binding corresponded well with the degree of
gene expression (Fig. 8b).
Next we aimed to identify the set of genes regulated
by INTS12 (i.e. its regulome). Genes were divided into
upregulated, downregulated and not differentially ex-
pressed following INTS12 knockdown. On average there
was 6-fold, 8-fold and 1.6-fold enrichment of INTS12
binding above genome background near the TSS of
upregulated, downregulated and not differentially ex-
pressed genes respectively (Fig. 8c). Thus of the total
number of downregulated and upregulated genes 92 and
85% of genes show evidence of INTS12 binding near
their promoters, while only 23% of genes that had no
evidence of differential expression showed this local-
ization. To provide validation for our findings we calcu-
lated the regulatory potential of INTS12 for each gene
based on evidence of near promoter (TSS ± 1000 bp)
binding as well as significance of differential expression
following D-siRNAs depletions, and plotted the ranked
list of genes based on their regulation versus cumulative
fraction of genes having a given or higher regulatory po-
tential score (Fig. 8d) [49]. Deregulated genes had sig-
nificantly greater regulatory potential scores than static
genes, with downregulated having lower P-value than
upregulated. This shows that the genes with evidence of
near promoter binding were contributing to the altered
expression following INTS12 knockdown, with bias for
supressed genes. Moreover, >90% of downregulated
genes had higher regulatory potential than upregulated
ones explaining more robust effects observed among the
downregulated pathways.
Motif enrichment and distribution uncovers INTS12 mode
of action
We next sought to understand if INTS12 binds to DNA
directly or in a cooperative fashion. Central motif en-
richment analysis can identify whether the precipitated
protein shows evidence of direct or cooperative DNA
binding based on the probability distribution of enriched
motif among its binding sites. Proteins with direct DNA
binding, such as transcription factors, display binding
sites clustering near the centres of the declared ChIPseq
peaks [50] and we leveraged this method to test the
most likely type of INTS12 binding. Using a differential
analysis approach [51], we identified an enrichment for a
motif among 20 and 12% of the total sites which
occurred only among 6 and 5% of background genome
sequences in the first and second donor respectively.
The same signature was recapitulated by a separate non-
differential algorithm [52]. The identified sequence was
compared to currently known motifs [53] and was found
to be identical to a motif previously found enriched
among binding sites of activator protein 1 [54], activat-
ing transcription factor 3, nuclear basic leucine zipper,
jun dimerization protein 2 [55, 56], nuclear factor eryth-
roid 2 as well as Fos-related antigen 2 [45]. Although
this motif appears to be centrally distributed, the site
probability is relatively broad (Fig. 8e) suggesting that
much of the binding via the identified motif occurs in
cooperation with other molecules. We conclude that
among the sites where the identified enriched motif oc-
curs, INTS12 does not have the characteristics of a tran-
scription factor and is more likely to act as a co-factor in
concert with other molecules.
Discussion
Our study provides key insights into the molecular and
cellular functions as well as the regulatory properties of
INTS12, a candidate lung function gene. Through lung
eQTL approach we present evidence that SNPs
associated with pulmonary parameters also correlate
with INTS12 expression, which is not the case for the
neighbouring GSTCD gene. eQTL analyses have sug-
gested that it is the altered expression of INTS12 as a
more likely driver of the genetic association for lung
function, but this has been based on the data obtained
from non-lung tissue [7]. Due to the diversity of tissue
gene expression, it is of pivotal importance to use
phenotype-relevant datasets [20]. A previous investiga-
tion of a lung microarray dataset [55, 56] failed to detect
a significant eQTL effect on INTS12. This may have
been due to the technical heterogeneity of hybridization-
based array assays [57]. Using a more sensitive lung
RNAseq dataset, in our eQTL analysis we were able to
detect the effect of lung function SNPs on INTS12
expression. It has become largely accepted that INTScom
exerts its effects via snRNA processing pathway, however
we find that in HBECs, among U1, U2, U4 and U5 species,
only U2 3’-end formation is affected following INTS12
knockdown.
The contribution of INTS12 to human snRNA processing
INTS12 is a member of the INTScom which itself has
been shown to be implicated in numerous molecular
and cellular processes. It remains unclear whether all
INTScom subunits are required for some of these pro-
cesses, especially that there is variability in the relative
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contributions of various complex members to snRNA
processing [9–12], maintenance of perinuclear dynein
[13] and ciliogenesis [17]. What remains to be elucidated
is how INTScom perturbations yield specific yet diverse
phenotypes.
It has been suggested that the primary mechanism
behind that is the alteration of snRNA 3’-end formation
affecting the splicing of mRNAs belonging to genes of
particular functional groups explaining the specific
phenotypic effects [13, 15, 16]. For instance, it has been
argued that the induced downregulation of INTS5,
INTS9, and INTS11 in zebrafish causes impaired haem-
atopoiesis due to aberrant splicing of smad1 and smad5
via a dominant negative form of these transcripts [16].
However, given the facts that INTS11 depletion results
in a loss of perinuclear dynein whilst there was no en-
richment for misprocessed transcripts encoding dynein-
dynactin subunits, adaptor molecules or dynein-binding
cassettes in HeLa cells [13] and our own observation of
minor effect of INTS12 knockdown on snRNA process-
ing concurrent with misbalanced protein synthesis, this
hypothesis seems unlikely in a human model. This is
further supported by a literature review of studies that
compared the contribution of various INTScom mem-
bers to snRNA processing, showing INTS12 to have a
fairly small role in comparison to other members of the
complex (Additional file 2: Table S6). Moreover, in the
overrepresentation analysis of genes with evidence of
D-siRNAs-reproducible altered splicing we found a poor
enrichment of only immune response pathways (e.g. class
I MHC mediated antigen processing and presentation;
FDR < 0.05) but none of genes with altered splicing were
part of any of the identified protein synthesis pathways
(data not shown). Therefore, partly based on our observa-
tion of poor correlation of INTS12 levels with the rest of
the complex in our datasets, alternatively we propose
INTScom subunits to have different activities despite their
physical association in the same complex and with POLII.
Consequently, the prediction from this model would be
that individual INTScom members are pleiotropic [58]
and have distinct functions which may explain the pleth-
ora of phenotypes observed following various perturba-
tions of INTScom.
Novel functional roles for INTS12
We have relied on a hypothesis-free approach [20] in
order to generate new functional hypotheses about
INTS12 function. Following its knockdown with two D-
siRNAs, we observed marked downregulation of pathways
critical in protein synthesis including tRNA synthetases,
unfolded protein response and PERK pathways. To further
investigate the importance of this, we undertook
additional experiments which showed that suppression of
INTS12 reduces protein synthesis and proliferative cap-
acity. Thus the identified molecular signature affected a
relevant phenotype, uncovering a new function for this
gene by demonstrating its role in regulating cellular trans-
lation. We have also detected upregulation of collagen
formation and extracellular matrix deposition, but the
effects upon the upregulated pathways were less robust.
We then performed INTS12 ChIPseq to delve deeper
into the mechanism behind the identified gene expression
changes. The top three fixed genomic features associated
with INTS12 binding were introns, intergenic regions and
promoters. A gene-centric analysis shows a distinct local-
ization near the TSS and TES for protein coding and
snRNA genes respectively. Moreover, INTS12 interaction
was enriched for canonical epigenetic marks of transcrip-
tion. The combined RNAseq and ChIPseq analyses re-
vealed preferential INTS12 binding to the expressed
rather than silenced genes and defined its regulome which
includes genes belonging to the aforementioned pathways.
INTS12 in evolution and development
It has been hypothesised that the mechanisms involved in
the early human lung development may alter lung function
(See figure on previous page.)
Fig. 8 Combination of ChIPseq and RNAseq following INTS12 depletion defines INTS12 regulome and mode of action. a Log2 fold change of INTS12
ChIPseq binding signal versus input control across gene bodies of expressed and silenced genes in basal HBECs. b Comparison of INTS12 binding vs.
corresponding gene expression in basal HBECs. Genes were ordered based on the level of INTS12 ChIPseq signal. The same sorted gene list was used to
evaluate their transcription in basal un-transfected HBECs where red colour indicates higher expression derived from read counts on the corresponding
gene bodies. c Average INTS12 binding profile for differentially expressed genes and genes with no evidence of differential expression following INTS12
depletion (left) as well as heatmap representation of this binding (right), with red indicating enrichment while green denoting lack of enrichment in
ChIPseq sample versus input control. d Prediction of the activating and repressive function of INTS12. The cumulative fraction of genes is plotted
against the regulatory potential, based on significance of representative D-siRNA A differential expression and ChIPseq evidence of binding near genes’
TSS. Regulatory potential is a product of the ranked potentials (RP ¼ rank Sg bindingð Þn 
rank Sg differential expressionð Þ
n Þ as judged by distance and number of INTS12
binding sites near gene’s TSS (Sg binding = ∑i = 1
k e− (0.5 + 4Δi)) and the potential as judged by significance of gene’s differential expression following INTS12
depletion (Sg differential expression =Q − value). INTS12 depletion was equally likely to induce or suppress gene expression in Kolmogorov-Smirnov test
but >90% of downregulated genes had a higher regulatory potential than upregulated genes explaining the more robust effects observed on
downregulated pathways. e Probability distribution of INTS12 binding enriched DNA motif TGAxTCA across the sites at which it is present. Position at
zero represents peak summit and motif appears to be centrally enriched 158 bp in each direction from this summit. The site probability curve is broad
(P = 2.7 × 10−17) indicating indirect or cooperative binding to the DNA
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and predispose to COPD later in life [59]. Although a sub-
set of lung function associated genes show evidence of dif-
ferential expression between various stages of embryonic
pulmonary tissue formation [20], there is still an incomplete
understanding of the molecular mechanisms behind normal
respiratory system development and how the alterations
therein contribute to disease pathophysiology. Given that
there is no homologous INTS12 in unsegmented C. elegans
or unicellular S. cerevisiae, its strong conservation and le-
thal effect of knockout in M. musculus, this gene may have
been important for the evolution of complex metazoan tis-
sue differentiation and specialization. This is also supported
by our observation of INTS12 binding association with ca-
nonical epigenetic marks of transcription which are known
to be reset during mammalian organogenesis [60]. It there-
fore seems plausible that INTS12 regulates lung develop-
ment or repair via a developmental pathway.
INTS12 knockdown induced gene dysregulation of
relevance to pulmonary physiology
INTS12 knockdown for 48 h and 120 h resulted in repro-
ducible dysregulation of core subset of genes important in
airway biology, such as SERPINA1, TGFβI, IL6, and IL8.
Of particular interest is LEP which had 4.51 and 29.16-
fold upregulation relative to control in D-siRNA A condi-
tion at 48 h and 120 h time points respectively. LEP
associates with the same lung function parameter as
INTS12 (6, 33) albeit weaker than what was reported for
4q24 locus. Crucially LEP levels negatively correlate with
lung function [34]. It is possible that reduced levels of
INTS12 in specific allele carriers are responsible for ele-
vated expression of LEP which may in turn account for re-
duced lung function. These causal hypotheses provide
biological understanding of the genetic association signal
for pulmonary function but require further exploration.
Conclusion
We conclude that INTS12 is a pleiotropic gene with at
least two different functions depending on the class of
genes where its binding occurs. In agreement with the ca-
nonical function, over snRNA genes INTS12 is likely to
contribute to their 3’-end formation. However, in contrast
to what was reported in Drosophila, INTS12 requirement
for snRNA processing is moderate in human cells
highlighting differences between these two species. Our
data identify a significant and previously unrecognized role
for INTS12 in protein synthesis control. A novel INTS12
regulome was uncovered and implies a regulation of pro-
tein coding genes belonging to the translational pathways.
Methods
Expression quantitative trait locus analysis
To functionally elucidate the GWAS signal for lung
function at 4q24 locus, a lung specific and RNAseq
based cis-eQTL dataset [21] was used. The nominal
P-values from testing the association between SNP vari-
ation and gene expression were obtained and corrected in
R using Benjamin-Hochberg FDR correction [61]. The
FDR values from eQTL analyses of 4q24 SNPs were com-
pared to the significance of association with lung function
parameter forced expiratory volume in a first second from
the Repapi et al. study [3].
RNA interference
The purpose of RNAi experiments was to deplete cells of
INTS12 in order to (a) study it in the context of existing
body of knowledge to translate canonical activity into a hu-
man model, (b) predict novel functions based on transcrip-
tomic profiling, (c) and to test them experientially. To help
distinguish between true and off-target effects, gene knock-
down was performed using two independent D-siRNAs.
Experiments included un-transfected and scrambled D-
siRNA transfected controls. RNAseq profiling was per-
formed 48 h and 120 h after the initiation of RNAi, to
compare the transcriptomic responses at these two time
points. RNAseq pathway analyses, functional and valid-
ation experiments were assessed using 120 h long interfer-
ence. INTS12 depletion was performed in discovery and
independent validation donor HBECs using a minimum of
three biological replicates.
RNAseq
RNA extraction from knockdown and control conditions,
cDNA library preparation and next generation sequencing
are described in Additional file 3: Supplemental Methods.
Quantitative PCR
U1, U2, U4 and U5 snRNA processing was assessed by
measuring qPCR-estimated relative levels of their respect-
ive misprocessed transcripts. MARS, GARS, ASNS, and
ATF4 expression was also measured by qPCR for technical
validation on the cDNA samples derived from RNA se-
quenced total RNA samples, and for biological validation
in different donor cells using the same experimental
design. Details of cDNA synthesis and qPCR assays are
described in Additional file 3: Supplemental Methods.
RNAseq and pathway data analyses
Detailed description of RNAseq and pathway analyses is
in the Additional file 3: Supplemental Methods.
ChIPseq and ChIP-PCR data analyses
ChIPseq and ChIP-PCR experimental procedures as well
as detailed description of ChIPseq data analyses are
described in Additional file 3: Supplemental Methods.
Kheirallah et al. BMC Genomics  (2017) 18:248 Page 17 of 20
Functional assays
Details about protein synthesis measurement and ana-
lyses are in the Supplemental Methods. Proliferative cap-
acity was assessed by cell counts and details are
described in Additional file 3: Supplemental Methods.
Immunofluorescence
Antibodies, immunofluorescence methods, and detection
are described in Additional file 3: Supplemental Methods.
Statistics
Data were grouped from multiple experiments and are
expressed as average ± standard error of mean. Statistical
significance was assessed by ordinary one-way ANOVA
followed by Fisher’s Least Significant Difference test.
Results were considered significant when P < 0.05. For high
throughput analyses the nominal P-values were corrected
for multiple comparisons using FDR correction. The signifi-
cance of dN/dS ratios in the selection test, was obtained via
the Single-Likelihood Ancestor Counting algorithm [62].
Additional files
Additional file 1: Figure S1–Figure S12. Contains all supplemental
figure data. Each figure has its legend. (PDF 3851 kb)
Additional file 2: Table S1–Table S6. Contains all supplemental table
data. Each table has its legend. (PDF 166 kb)
Additional file 3: Contains a more detailed supplemental information in
relation to the methods: Cell Culture, RNAi, RNAseq, qPCR, RNAseq and
Pathway Data Analysis [63], Protein synthesis by 35S-Methionine
incorporation assay [64], Assessment of proliferative capacity by cell
counts, ChIPseq, ChIP-PCR, ChIPseq Data Analysis [65–68], ENCODE data
retrieval and analysis [69], Immunofluorescence [70]. (PDF 89 kb)
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